MOTS-c (human) acetate is a blood-brain barrier-penetrating, mitochondrial-derived peptide that modulates the AMPK/PGC-1α pathway to enhance insulin sensitivity. It also regulates antioxidant and inflammatory pathways, promotes mitochondrial biogenesis, and improves glucose and lipid metabolism. It is studied for type 2 diabetes, traumatic brain injury, inflammatory diseases, and aging-related metabolic disorders.
- Blood-brain barrier-penetrating mitochondrial peptide.
- Enhances insulin sensitivity via AMPK/PGC-1α modulation.
- Regulates antioxidant and inflammatory pathways.
- Promotes mitochondrial biogenesis.
- Improves glucose and lipid metabolism.
- Anti-oxidative, anti-inflammatory, and neuroprotective.
- Applications in diabetes, TBI, inflammatory, and aging studies.